HealthCare Institute of New Jersey Statement on Vital Transformation Report on Price Controls
Dean J. Paranicas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning recent discussions in Washington on potential drug pricing legislation.